Gastric Carcinoma — Trials

Gastric Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

586 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 183
Recruiting: 93
Ph III recruiting: 15
Growth YoY: +4.3%
Industry share: 21%
Top sponsor: National Cancer Institute (NCI)
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (65)

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07603349	Adaptive Adjuvant Therapy After Neoadjuvant Therapy and Gastrectomy for Gastric or Gastroesophageal Junction Adenocarcinoma	not yet recruiting	Phase 2 / Phase 3	405	Nanfang Hospital, Southern Medical UniversityOTHER	1	May 22, 2026	clinicaltrials
NCT07332533	A Study of KN026-based Combination Therapy in HER2-positive Gastric Cancer	not yet recruiting	Phase 2 / Phase 3	490	Shanghai JMT-Bio Inc.INDUSTRY	0	Jan 12, 2026